ClinConnect ClinConnect Logo
Search / Trial NCT01973985

Using Ultrasound to Predict the Results of Draining Pleural Effusions

Launched by UNIVERSITY OF OXFORD · Oct 25, 2013

Trial Information

Current as of June 28, 2025

Terminated

Keywords

Pleural Effusion

ClinConnect Summary

Study-specific interventions will be the monitoring of intrapleural pressure using an electronic pleural manometer (Mirador Biomedical CompassTM Thoracentesis Assist Device) and thoracic ultrasonography. Both of these are considered non-invasive and low-risk to the study participants.

As part of their standard usual clinical care, participants will undergo a diagnostic and/or therapeutic pleural intervention in the form of thoracocentesis or pleural aspiration; intercostal chest drain insertion; and/or talc pleurodesis. All of these procedures are invasive and associated with potential com...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The participant is willing and able to give informed consent for participation in the study.
  • Adult male or female, aged 18 years or above.
  • Diagnosed with a symptomatic pleural effusion requiring either diagnostic and/or therapeutic pleural aspiration or drainage.
  • Expectation by the clinician responsible for assessing the patient that more than 500mL of pleural fluid will be drained on this particular occasion.
  • Exclusion Criteria:
  • Age less than 18 years
  • Inability to provide informed consent
  • Evidence of significant septation or loculation within the pleural effusion as determined by the clinician responsible for assessing the patient.

About University Of Oxford

The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.

Locations

Oxford, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Najib Rahman, DPhil, MSc, MRCP

Study Chair

University of Oxford & Oxford University Hospitals NHS Trust

John Corcoran, MD

Principal Investigator

University of Oxford

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials